Motley Fool Australia
  •  

    Notifications

    Scott

    Wondering where you should invest $1,000 right now?

    Scott Phillips just released his 5 best stocks to buy right now and you could grab the names of these stocks instantly!

    Learn More
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Etfs S&p Biotech ETF (ASX: CURE)
    3. /

Etfs S&p Biotech ETF (ASX: CURE) Share Price and News

Price

$43.57

Movement

0.44 (-1.0%)

As at 13 Jun - Closed (20 mins delayed)

52 Week Range

$38.76 - $54.72

 
1 Year Return

-10.28%

Etfs S&p Biotech ETF Chart and Price Data

2025
2025
2025
2025
$30
$40
$50
$60
$30
$40
$50
$60
$30
$40
$50
$60
$30
$40
$50
$60

Fundamentals Data provided by Morningstar.

Share Price

$43.57

Day Change

0.44 (-1.0%)

52 Week Range

$38.76 - $54.72

Yesterday's Close

$44.01

Today's Open

$43.90

Days Range

$42.96 - $43.90

Volume

3,367

Avg. Volume (1 month)

1,677

Turnover

$146,513

As at 13 Jun - Closed

    • Etfs S&p Biotech ETF (ASX: CURE)
    Latest News

    ETF written in yellow with a yellow underline and the full word spelt out in white underneath.
    ETFs

    2 top ETFs for ASX investors to buy in October

    | James Mickleboro

    These ETFs could be top options for investors in October...

    Read more »

    A young woman sits with her hand to her chin staring off to the side thinking about her investments.
    ETFs

    2 exciting ETFs named as buys by experts

    | James Mickleboro

    Here are two ETFs that could be buys...

    Read more »

    CURE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    5th Jun 2025 2025-06-05T17:19:04 Global X Units on Issue - May 2025YesNo5:19pm4238k
    6th May 2025 2025-05-06T17:34:19 Global X Units on Issue - April 2025YesNo5:34pm4238k
    30th Apr 2025 2025-04-30T13:08:04 PDS dated 15 April 2025YesNo1:08pm114919k
    4th Apr 2025 2025-04-04T16:49:06 Global X Units on Issue - March 2025YesNo4:49pm4236k
    14th Mar 2025 2025-03-14T16:28:04 Half Year AccountsYesNo4:28pm19851k
    6th Mar 2025 2025-03-06T17:50:37 Global X Units on Issue - February 2025YesNo5:50pm4235k
    13th Feb 2025 2025-02-13T13:40:45 PDS dated 12 February 2025YesNo1:40pm106925k
    6th Feb 2025 2025-02-06T09:36:40 Global X Units on Issue - January 2025YesNo9:36am4233k
    7th Jan 2025 2025-01-07T09:15:05 Global X Units on Issue - December 2024YesNo9:15am4224k
    5th Dec 2024 2024-12-05T09:12:19 Global X Units on Issue - November 2024YesNo9:12am4243k

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Oliver Joseph Reynolds Non-Executive Director Sep 2023
    Mr Reynolds has over 20 years of experience in financial services and investment management, with experience leading finance, operations, risk management, compliance, investment, strategy and management teams. Oliver previously worked at BlackRock, and most recently at Coolabah Capital as Chief Financial Officer.
    Mr Evan Metcalf Non-Executive Director Jun 2022
    Mr Metcalf has more than 20 years of experience in financial services which includes derivative structuring roles at Credit Suisse and ANZ, as well as a role as a quantitative analyst at Westpac
    Young Kim Non-Executive Director Jun 2022
    No Profile Reported in Annual Report.
    Mr Namki Kim Non-Executive Director Jul 2024
    --
    Mr Emanual Damianakis Non-Executive Director Aug 2024
    --

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 Shareholder Information 0 0.00%

    Profile

    since

    Note